Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy

被引:0
|
作者
Mirelis, Jesus G. [1 ,2 ,3 ]
Sanchez-Gonzalez, Javier [1 ,4 ]
Zorio, Esther [5 ]
Ripoll-Vera, Tomas [6 ]
Salguero-Bodes, Rafael [7 ]
Filgueiras-Rama, David [1 ,2 ,8 ]
Gonzalez-Lopez, Esther [1 ,2 ,3 ]
Gallego-Delgado, Maria [1 ,2 ]
Fernandez-Jimenez, Rodrigo [1 ,2 ,9 ]
Jesus Soleto, Maria [6 ]
Nunez, Juana [6 ]
Pizarro, Gonzalo [1 ,2 ,10 ]
Sanz, Javier [9 ]
Fuster, Valentin [1 ,9 ]
Garcia-Pavia, Pablo [1 ,2 ]
Ibanez, Borja [1 ,2 ,11 ]
机构
[1] Inst Salud Carlos III, CNIC, Area Fisiopatol Miocardio, Madrid, Spain
[2] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain
[3] Hosp Univ Puerta Hierro, Dept Cardiol, Madrid, Spain
[4] Philips Healthcare, Dept Ciencia Clin, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Dept Cardiol, Valencia, Spain
[6] Hosp Son Llatzer & IdISPa, Dept Cardiol, Palma de Mallorca, Spain
[7] Hosp Univ 12 Octubre, Dept Cardiol, Madrid, Spain
[8] Hosp Univ Clin San Carlos, Dept Cardiol, Madrid, Spain
[9] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Dept Cardiol, New York, NY 10029 USA
[10] Univ Europea Madrid, Complejo Hosp Ruber Juan Bravo, Dept Cardiol, Madrid, Spain
[11] IIS Hosp Fundac Jimenez Diaz, Dept Cardiol, Madrid, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2017年 / 70卷 / 11期
关键词
Hypertrophic cardiomyopathy; Computed tomography; Extracellular volume; Diffuse fibrosis; CARDIAC MAGNETIC-RESONANCE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; 2011 ACCF/AHA GUIDELINE; SUDDEN-DEATH; TASK-FORCE; PROGNOSTIC VALUE; FIBROSIS; PREVALENCE; PREVENTION; DIAGNOSIS;
D O I
10.1016/j.recesp.2017.01.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Myocardial interstitial fibrosis, a hallmark of hypertrophic cardiomyopathy (HCM), has been proposed as an arrhythmic substrate. Fibrosis is associated with increased extracellular volume (ECV), which can be quantified by computed tomography (CT). We aimed to analyze the association between CT-determined ECV and malignant ventricular arrhythmias. Methods: A retrospective case-control observational study was conducted in HCM patients with implantable cardioverter-defibrillator, undergoing a CT-protocol with continuous iodine contrast infusion to determine equilibrium ECV. Left ventricular septal and lateral CT-determined ECV was compared between prespecified cases (malignant arrhythmia any time before CT scan) and controls (no prior malignant arrhythmias) and among ECV tertiles. Results: A total of 78 implantable cardioverter-defibrillator HCM patients were included; 24 were women, with a mean age of 52.1 +/- 15.6 years. Mean ECV +/- standard deviation in the septal left ventricular wall and was 29.8% +/- 6.3% in cases (n = 24) vs 31.9% +/- 8.5% in controls (n = 54); P=.282. Mean ECV in the lateral wall was 24.5% +/- 6.8% in cases vs 28.2% +/- 7.4% in controls; P=.043. On comparison of the entire population according to septal ECV tertiles, no significant differences were found in the number of patients receiving appropriate shocks. Conversely, we found a trend (P=.056) for a higher number of patients receiving appropriate shocks in the lateral ECV lowest tertile. Conclusions: Extracellular volume was not increased in implantable cardioverter-defibrillator HCM patients with malignant ventricular arrhythmias vs those without arrhythmias. Our findings do not support the use of ECV (a surrogate of diffuse fibrosis) as a predictor of arrhythmias in high-risk HCM patients. (C) 2017 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:933 / 940
页数:8
相关论文
共 50 条
  • [41] Microvolt QRS Alternans in Hypertrophic Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias
    Chakraborty, Praloy
    Suszko, Adrian M.
    Viswanathan, Karthik
    Sheikholeslami, Kimia
    Spears, Danna
    Adler, Arnon
    Woo, Anna
    Rakowski, Harry
    Chauhan, Vijay S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [42] Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy
    Di Marco, Andrea
    Brown, Pamela F.
    Bradley, Joshua
    Nucifora, Gaetano
    Anguera, Ignasi
    Miller, Christopher A.
    Schmitt, Matthias
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2023, 24 (04) : 512 - 521
  • [43] Epicardial adipose tissue accumulation is associated with malignant ventricular arrhythmias in phospholamban cardiomyopathy
    Mahmoud, B.
    De Brouwer, R.
    Kuster, D. W. D.
    Van der Velden, J.
    Van Veldhuisen, D. J.
    De Boer, R. A.
    Westenbrink, B. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 7 - 7
  • [44] LATE GADOLINIUM ENHANCEMENT AND EXTRACELLULAR VOLUME AS MARKERS OF ARRHYTHMIA RISK IN HYPERTROPHIC CARDIOMYOPATHY
    Levine, Jonathan
    Murtagh, Gillian
    Collins, Jeremy
    Carr, James
    Choudhury, Lubna
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1537 - 1537
  • [45] Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy
    Almaas, Vibeke M.
    Haugaa, Kristina H.
    Strom, Erik H.
    Scott, Helge
    Dahl, Christen P.
    Leren, Trond P.
    Geiran, Odd R.
    Endresen, Knut
    Edvardsen, Thor
    Aakhus, Svend
    Amlie, Jan Peder
    EUROPACE, 2013, 15 (09): : 1319 - 1327
  • [46] Atrial Function Assessment in High-Risk Hypertrophic Cardiomyopathy Reply
    Candan, Oezkan
    Gecmen, Cetin
    Kahyaoglu, Muzaffer
    celik, Mehmet
    Simsek, Zeki
    Dindas, Ferhat
    Dogdus, Mustafa
    Zehir, Regayip
    Kirma, Cevat
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (02): : 123 - 124
  • [47] HYPERTROPHIC CARDIOMYOPATHY - A DISEASE OF GOOD PROGNOSIS DESPITE THE HIGH-INCIDENCE OF VENTRICULAR ARRHYTHMIAS
    ARTEAGA, E
    BARRETTO, ACP
    MADY, C
    IANNI, BM
    IANNI, M
    HOSNI, JJ
    BELOTTI, G
    CIRCULATION, 1995, 92 (08) : 466 - 466
  • [48] Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy
    Cha, Yong-Mei
    Gersh, Bernard J.
    Maron, Barry J.
    Boriani, Giuseppe
    Spirito, Paolo
    Hodge, David O.
    Weivoda, Peggy L.
    Trusty, Jane M.
    Friedman, Paul A.
    Hammill, Stephen C.
    Rea, Robert F.
    Shen, Win-Kuang
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (05) : 483 - 487
  • [49] Effects of low-dose amiodarone and Betaloc on the treatment of hypertrophic cardiomyopathy complicated with malignant ventricular arrhythmias
    Gao, Yu
    Zhang, Peisheng
    Liang, Xue
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2014, 30 (02) : 291 - 294
  • [50] Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy
    Haland, Trine F.
    Almaas, Vibeke M.
    Hasselberg, Nina E.
    Saberniak, Jorg
    Leren, Ida S.
    Hopp, Einar
    Edvardsen, Thor
    Haugaa, Kristina H.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2016, 17 (06) : 613 - 621